MRD-CLL Panel
Commonly Known As:
MRD-CLL Panel
The panel helps evaluate minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) patients. It identifies and quantifies residual leukemia cells that may remain after treatment, providing crucial information about disease remission and relapse risk.
Test Preparation :
No Special Preparation. Informed Consent Required.
Reporting TAT :
4 Day
Specialisation(S) :
Test parameters includes :
No tests are mapped to this service.
Visit Type
Centre Visit
Are you Looking for Online Appointment?